s6y
Company name or ticker
Search
Compass Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Thursday, April 27, 2023
Period
Jun 15, 2023
Accession number
0001140361-23-020957
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header